Antiretroviral treatment in 1998
- 1 December 1998
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 352 (9144) , 1919-1922
- https://doi.org/10.1016/s0140-6736(98)07532-1
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- HIV/AIDS treatment: lessons from the tuberculosis experienceDrug Resistance Updates, 1998
- One world, one hopeAIDS, 1998
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Antiretroviral Therapy for HIV Infection in 1997JAMA, 1997
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997
- Antiretroviral Therapy for HIV Infection in 1996JAMA, 1996
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996